Tag: Nasdaq:HCM

5 Top Pharmaceutical News Stories of 2018

What pharmaceutical news stories caught investors' attention in 2018? We run through our five most popular articles.

Chi-Med and Eli Lilly Launch Elunate in China

The drug is available in capsule form to treat metastatic colorectal cancer for patients that have undergone previous treatments.

Chi-Med Initiates a Phase I Trial of HMPL-523 in Combination with Azacitidine in Elderly Patients with Acute Myeloid Leukemia in China

Hutchison China MediTech (AIM/Nasdaq:HCM) has initiated a Phase I study of HMPL-523, its novel spleen tyrosine kinase inhibitor, in combination...